Rheumatic disorders associated with hepatitis C

M R Lövy1, G Starkebaum

  • 1University of Washington, 1310 S Union, Suite A, Tacoma, WA 98405, USA.

Insights

Hepatitis C virus (HCV) infection is widespread and can lead to rheumatic and immunological disorders. This review guides healthcare professionals in diagnosing and managing these complex cases.

Area of Science:

  • Hepatology
  • Rheumatology
  • Immunology

Background:

  • Hepatitis C virus (HCV) affects up to 3% of the global population, with genetic diversity contributing to chronic infections.
  • HCV infection often presents asymptomatically, with patients later developing rheumatic and immunological disorders.
  • These disorders require specialized attention from rheumatologists and other healthcare professionals.

Purpose of the Study:

  • To review clinical observations of rheumatological and immunological diseases associated with HCV infection.
  • To present information on HCV molecular biology and diagnostic approaches.
  • To offer guidance on differential diagnosis, patient management, and therapy for HCV patients with rheumatic conditions.

Main Methods:

  • Literature review of clinical observations, molecular biology, and diagnostic studies related to HCV.
  • Analysis of differential diagnosis for liver and rheumatic disorders in HCV patients.
  • Synthesis of practical guidelines for history taking, physical examination, laboratory work-up, monitoring, and treatment.

Main Results:

  • HCV infection is linked to a spectrum of rheumatological and immunological conditions.
  • Understanding HCV's genetic diversity and quasi-species nature is crucial for managing chronic infections.
  • Current diagnostic tools and therapeutic strategies for HCV-associated rheumatic disorders are discussed.

Conclusions:

  • HCV infection necessitates a multidisciplinary approach involving rheumatologists and hepatologists.
  • Early recognition and appropriate management of HCV-related rheumatic diseases are essential for patient outcomes.
  • This review provides a comprehensive resource for clinicians managing HCV patients with rheumatic manifestations.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...